Analysis of safety data in clinical trials using a recurrent event approach

Pharmaceutical Statistics

Volumn 13, Issue 2, 2014, Pages 136-144

  Gong, Qi ^a   Tong, Barbara ^b   Strasak, Alexander ^c   Fang, Liang ^d  

^a AMGEN INC   (United States)

^b GENENTECH INC   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d GILEAD SCIENCES   (United States)

Author keywords

benefit risk assessment; informative censoring; log rank test; mean frequency function; terminal event

Indexed keywords

ADVERSE OUTCOME; ARTICLE; COMPARATIVE STUDY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DATA ANALYSIS; GLOBAL ASSESSMENT OF FUNCTIONING; HEALTH CARE QUALITY; HUMAN; INCIDENCE; LOG RANK TEST; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; TERMINAL CARE; CLINICAL TRIAL (TOPIC); PATIENT SAFETY; STATISTICAL ANALYSIS;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; PATIENT SAFETY;

EID: 84896699777     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1611     Document Type: Article

References (16)

1. Chuang-Stein C, Mohberg NR, Musselman DM,. Organization and analysis of safety data using a multivariate approach. Statistics in Medicine 1992; 11: 1075-89.
2. Nishikawa M, Tango T, Ogawa M,. Non-parametric inference of adverse events under informative censoring. Statistics in Medicine 2006; 25: 3981-4003.
3. Amit O, Heiberger RM, Lane PW,. Graphical approaches to the analysis of safety data from clinical trials. Pharmaceutical Statistics 2008; 7: 20-35.
4. Berry SM, Berry DA,. Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture model. Biometrics 2004; 60: 418-26.
5. Anderson PK, Gill RD,. Cox's regression model for counting processes: a large sample study. The Annals of Statistics 1982; 4: 1100-20.
6. Prentice RL, Williams BJ,. On the regression analysis of multivariate failure time data. Biometrika 1981; 68: 373-79.
7. Wei LJ, Lin DY, Weissfeld L,. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. Journal of the American Statistical Association 1989; 84: 1065-73.
8. Cook RJ, Lawless JF,. Marginal analysis of recurrent events and a terminating event. Statistics in Medicine 1997; 16: 911-24.
9. Ghosh D, Lin DY,. Nonparametric analysis of recurrent events and death. Biometrics 2000; 56: 554-62.
10. Chen BE, Cook R,. Tests for multivariate recurrent events in the presence of a terminal event. Biostatistics 2004; 5: 129-43.
11. Guttner A, Kubler J, Pigeot I,. Multivariate time-to-event analysis of multiple adverse events of drugs in integrated analyses. Statistics in Medicine 2007; 26: 1518-31.
12. Guo JJ, Pandey S, Doyle J, Bian B, Lis Y, Raisch D,. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. Value in Health 2010; 13: 657-66.
13. Liu L, Wolfe RA, Huang X,. Shared frailty models for recurrent events and a terminal event. Biometrics 2004; 60: 747-56.
14. Li QH, Lagakos SW,. Use of the Wei-Lin-Weissfeld method for the analysis of recurring and a terminating event. Statistics in Medicine 1997; 16: 925-40.
15. Ye Y, Kalbfleisch JD, Schaubel E,. Semiparametric analysis of correlated recurrent and terminal events. Biometrics 2007; 63: 78-87.
16. Wang J, Quartey G,. Nonparametric estimation for cumulative duration of adverse events. Biometrical Journal 2012; 54: 61-74.